Почетна › Беркитов лимфом › Alabama › Birmingham

Kliničke studije za Беркитов лимфом u gradu Birmingham, AL

7 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Birmingham i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2

Children's Hospital of Alabama, Birmingham

Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2

Children's Hospital of Alabama, Birmingham

365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2

Children's Hospital of Alabama, Birmingham

366 Days – 46 Years · Оба пола · Ажурирано 27. 10. 2026. · NCT06124157

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3

Children's Hospital of Alabama, Birmingham

365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL

Тражи се учесникФаза 1

University of Alabama at Birmingham, Birmingham

Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2025. · NCT04260022

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Тражи се учесникФаза 2

Children's of Alabama/University of Alabama in Birmingham(UAB), Birmingham

Узраст од 1 до 25 · Оба пола · Ажурирано 4. 5. 2025. · NCT03509961

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Тражи се учесникФаза 1

University of Alabama at Birmingham, Birmingham

Узраст 18 и старији · Оба пола · Ажурирано 15. 11. 2024. · NCT06034275

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Birmingham

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.